Prostate Cancer affects only men, unfortunately is one of most common cancer between men.(e.g. for American Cancer Society. Only in US there are 161,360 new estimated cases in 2017 and an incidence rates 2009-2013 of 123.2).
This particular pathology often shows no early sytnoms, but it can be found anyway early by testing the amount of prostate-specific antigen (PSA) in a man’s blood, or with the digital rectal exam (DRE).
Recently in Vienna was developed a blood test that could improve the survival rate of patients with advanced prostate cancer. About this test, Dr Matthew Hobbs, from Prostate Cancer UK, said: “The results from this study […] give an important understanding of the factors that drive certain prostate cancers, or make them vulnerable to specific treatments.”
If you are interested to read the full article you can find it on the BBC News site.